Psychiatry and Neurology, Neurology · Plantation, FL
NPI
1437167129
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
260 SW 84th Ave Ste C
Plantation, FL, 33324
Phone (954) 361-3116
Groups this clinician bills Medicare through
Medicare paid, 2024
$145K
12,757 services
Medicare patients, 2024
385
Average age 75
Drug cost, 2024
$5.1M
1,964 prescriptions
Company payments, 2025
$7,595
From 45 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ramesh Gopalaswamy was code 99214 (office e&m - established), 410 times for 180 patients. In total Ramesh Gopalaswamy billed 12,757 services in 35 codes, and Medicare paid $145K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-09-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 410 | 180 | $94.95 | $39K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 302 | 167 | $12.48 | $3,768 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 127 | 127 | $18.83 | $2,391 |
| 99215 Office E&M - Established | Office | 113 | 79 | $141.99 | $16K |
| 99204 Office E&M - New | Office | 82 | 82 | $121.62 | $9,973 |
| 95886 Electrical Nerve Conductivity | Office | 53 | 26 | $88.59 | $4,695 |
| 92060 Vision, Hearing, and Speech Services | Office | 49 | 27 | $48.19 | $2,361 |
| 99223 Hospital E&M - Initial | Facility | 42 | 42 | $143.63 | $6,032 |
| 99222 Hospital E&M - Initial | Facility | 42 | 42 | $110.61 | $4,646 |
| 92014 Ophthalmological E&M | Office | 41 | 17 | $87.33 | $3,580 |
| 92004 Ophthalmological E&M | Office | 33 | 33 | $115.46 | $3,810 |
| 95816 Neurologic | Office | 27 | 27 | $310.60 | $8,386 |
| 92201 Ophthalmological E&M | Office | 24 | 24 | $19.12 | $459 |
| 92083 Vision, Hearing, and Speech Services | Office | 18 | 17 | $50.09 | $902 |
| 95910 Electrical Nerve Conductivity | Office | 17 | 17 | $138.85 | $2,360 |
By year: 2022 $129K for 2,308 services; 2023 $137K for 1,717 services; 2024 $145K for 12,757 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ramesh Gopalaswamy prescribed most often to Medicare patients was Memantine Hcl, with 303 prescriptions and refills. In total Ramesh Gopalaswamy wrote 1,964 Medicare prescriptions that cost $5.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Memantine Hcl Generic | 303 | 563 | 79 | $9,772 |
| Donepezil Hcl Generic | 148 | 350 | 43 | $1,412 |
| Gabapentin Generic | 148 | 172 | 42 | $1,860 |
| Gamunex-C Immune Globul G/Gly/Iga Avg 46 | 110 | 110 | Under 11 | $759K |
| Pregabalin Generic | 82 | 94 | 16 | $1,795 |
| Primidone Generic | 73 | 139 | 17 | $1,385 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 65 | 150 | 19 | $730 |
| Levetiracetam Generic | 50 | 103 | 13 | $1,181 |
| Clonazepam Generic | 43 | 48 | Under 11 | $572 |
| Topiramate Generic | 39 | 75 | Under 11 | $416 |
| Pyridostigmine Bromide Generic | 34 | 66 | 11 | $1,810 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 34 | 34 | Under 11 | $880 |
| Escitalopram Oxalate Generic | 30 | 60 | Under 11 | $417 |
| Nortriptyline Hcl Generic | 28 | 33 | Under 11 | $418 |
| Duloxetine Hcl Generic | 24 | 36 | Under 11 | $406 |
Brand drugs: 462 claims; generic drugs: 1,502 claims; opioid claims: 44.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ramesh Gopalaswamy $7,595 ($7,595 in general payments such as food, travel and fees) from 45 companies. The largest payer was Abbvie Inc. with $885.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.